Why cervical cancer is no longer a ‘later-life’ disease
Cervical cancer cases are rising among younger women, shifting from its traditional association with those in their 40s and 50s. This trend stems primarily from early HPV exposure, low vaccination rates, and delayed screening.
Early sexual activity increases HPV infection risk, as the virus—responsible for 95-98% of cases—often persists unnoticed in young women. Low HPV vaccination uptake, due to myths, limited awareness, and missed adolescent windows, leaves many unprotected. Delayed or skipped screenings, exacerbated by pandemic disruptions and stigma, allow precancerous changes to progress silently.
Supporting Trends
-
In the US, rates rose 1.7-2.5% annually from 2012-2019 for women aged 30-44, reversing prior declines.
-
In India, gynecologists report more precancerous lesions and early cancers in young patients, linked to ignored symptoms like irregular bleeding.
-
Factors like smoking, multiple partners, and weakened immunity (e.g., HIV) amplify risks in this group.
HPV vaccination before sexual debut offers up to 98% protection; screening via Pap/HPV tests from age 21 detects issues early. Addressing access barriers and myths through education can reverse this shift.
